JOELLE GIRON: Open Payments
NPI 1548958093 · SAN MARCOS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 34 payments from 21 companies in 2025. Trend: 2023 $191 · 2024 $155 · 2025 $685
Food & beverage: $685
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $103 |
| Regeneron Healthcare Solutions, Inc. | 2 | $76 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| QOL Medical, LLC | 2 | $48 |
| PFIZER INC. | 3 | $48 |
| Novo Nordisk Inc | 2 | $39 |
| AtriCure, Inc. | 1 | $30 |
| Aimmune Therapeutics, Inc. | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Madrigal Pharmaceuticals | 1 | $28 |
Products named: DUPIXENT, Sucraid, ELIQUIS, LINZESS, Ozempic, TRELEGY ELLIPTA, ATRICLIP LAA EXCLUSION SYSTEM, ZENPEP.
Industry payments across TX — which companies pay providers there.
